LICENSE AGREEMENTLicense Agreement • July 29th, 2014 • Celgene Corp /De/ • Pharmaceutical preparations • New York
This License Agreement (this “Agreement”), dated as of April 23, 2014 (the “Execution Date”), is made by and between Nogra Pharma Limited, organized under the laws of Ireland having business offices at 33 Sir John Rogerson’s Quay, Dublin 2, Ireland (“Nogra”), and Celgene Corporation, a Delaware corporation (“Celgene Corp.”), with respect to all rights and obligations under this Agreement in the United States (subject to Section 13.16), and Celgene Alpine Investment Company II LLC, a Delaware limited liability company (“Celgene Alpine”), with respect to all rights and obligations under this Agreement outside of the United States (subject to Section 13.16) (Celgene Alpine and Celgene Corp. together, “Licensee”). Nogra and Licensee are sometimes hereinafter referred to each as a “Party” and collectively as the “Parties.”
